Photo:AFP
Pune: The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca COVID-19 vaccine.
"We have received the (purchase) order from the Government of India on Monday afternoon," a senior SII official told PTI.
Centre has placed purchase order with Serum Institute for 11 million doses of Covishield vaccine each costing Rs 200.
The government has already announced that the process of administering the vaccine will start on on January 16.
The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.
PTI
RELATED STORIES
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.
.jpg?$p=e46f401&q=0.8&f=16x11&w=104)
